Fatty Liver Disease (FLD) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2; Overweight and Obesity; Non-Alcoholic Fatty Liver Disease; Metabolic Syndrome Interventions: Other: Dietary macronutrient composition Sponsors: Hvidovre University Hospital; University of Copenhagen; Danish Research Centre for Magnetic Resonance Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials

Benefits of Trimetazidine in MAFLD Pateints
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Drug: conventional treatment; Drug: Furosemide or other alternatives , Niaspan or other alternatives; Drug: Trimetazidine Sponsors: October 6 University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials

A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria
Conditions: Hyperoxaluria; Nonalcoholic Fatty Liver Disease; Kidney Stone Interventions: Drug: BMN 255; Drug: Placebo Sponsors: BioMarin Pharmaceutical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials

ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial
Conditions: Obesity; Liver Diseases; Liver Fibrosis; Liver Fat; NAFLD; Weight Loss; Insulin Resistance; Insulin Sensitivity; Insulin Sensitivity/Resistance; Metabolic Diseases; Diabetes; Diabetes Mellitus, Type 2; Diabetes Mellitus; NASH With Fibrosis; Non-Alcoholic Fatty Liver Disease; Non Alcoholic Fatty Liver; Non-alcoholic Steatohepatitis Interventions: Device: ESG; Drug: GLP1-RA Sponsors: Pichamol Jirapinyo, MD, MPH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials

Association Betweenq MAFLD ( Metabolic Associated Fatty Liver Disease) and Chronic Kidney Disease
Conditions: Mafld in Ckd Patients Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials

Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies
Conditions: Metabolic Dysfunction-associated Fatty Liver Disease; Cirrhosis Interventions: Drug: Pioglitazone metformin tablets; Drug: Other drugs; Other: Drug-free Sponsors: The Affiliated Hospital of Hangzhou Normal University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials

Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Drug: Standard Soy Milk; Drug: 2% Fat Cow ' s Milk Sponsors: Marialena Mouzaki Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials

Echocardiographic Findings as Markers of Subclinical Cardiac Dysfunction in Patients With Non-Alcoholic Fatty Liver Disease
Conditions: NAFLD Interventions: Device: Echocardiographic findings Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials

Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)
Conditions: Non-Alcoholic Fatty Liver Disease (NAFLD) Interventions: Drug: Proliverenol; Drug: Placebo caplets of Proliverenol Sponsors: Dexa Medica Group; PT Equilab International Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials

Dexamethasone/Pancreatic Clamp P & F
Conditions: Insulin Resistance; Prediabetic State; Non-Alcoholic Fatty Liver Disease; Overweight and Obesity Interventions: Drug: Insulin human; Drug: Octreotide Acetate; Drug: Glucagon; Drug: Human Growth Hormone; Drug: Dexamethasone Oral; Other: [6,6-2H2] D-glucose; Drug: 20% D-glucose (aq); Dietary Supplement: BOOST Plus; Device: Harvard Apparatus PHD ULTRA CP syringe pump; Device: Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer; Other: Normal saline; Other: Human albumin Sponsors: Columbia University; Albert Einstein College of Medicine; National Institute of Diabetes and Digestive and Kidne...
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials

The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus
Conditions: Fatty Liver, Nonalcoholic Interventions: Drug: SGLT2 inhibitor Sponsors: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials

Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program
Conditions: Diabetes Mellitus Type 2, Diabetes Mellitus Type 1; NAFLD - Nonalcoholic Fatty Liver Disease; PreDiabetes Sponsors: Dasman Diabetes Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials

The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease
Conditions: HIV; Non-Alcoholic Fatty Liver Disease; Metabolic-Associated Steatotic Liver Disease Interventions: Dietary Supplement: Prebiotic; Dietary Supplement: Probiotic Sponsors: Vanderbilt University Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials

Dose Exploration Study of GSK4532990 in Participants With NASH or Suspected NASH
Conditions: Non-alcoholic Fatty Liver Disease Interventions: Drug: GSK4532990 Sponsors: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials

The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A
Conditions: NAFLD Interventions: Dietary Supplement: Soy isoflavone; Other: Placebo Sponsors: Ahvaz Jundishapur University of Medical Sciences Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials